LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Search

Takeda Pharmaceutical Co Ltd ADR

Avatud

Sektor Tervishoid

14.08 0.86

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

13.92

Max

14.1

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+6.02 upside

Uudiste sentiment

By Acuity

50%

50%

167 / 390 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Takeda Pharmaceutical Co Ltd ADR Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. okt 2024, 07:27 UTC

Tulu

Takeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance -- Update

31. okt 2024, 06:44 UTC

Tulu

Takeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance

31. juuli 2024, 07:19 UTC

Tulu

Takeda Pharmaceutical's First-Quarter Profit Rose on Higher Revenue -- Update

31. juuli 2024, 06:29 UTC

Tulu

Takeda Pharmaceutical Reports Rise in First-Quarter Net Profit on Higher Revenue

17. juuni 2024, 13:34 UTC

Suurimad hinnamuutused turgudel

Ovid Therapeutics Shares Slide Premarket After Takeda's Soticlestat Setback

13. mai 2024, 11:26 UTC

Suurimad hinnamuutused turgudel

AC Immunity Shares Soar on Exclusive License Deal with Takeda

9. mai 2024, 07:37 UTC

Tulu

Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss -- Update

9. mai 2024, 07:08 UTC

Tulu

Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss

1. veebr 2024, 07:32 UTC

Tulu

Takeda Pharmaceutical's Third-Quarter Net Profit Dropped on Lower Margins -- Update

1. veebr 2024, 06:55 UTC

Tulu

Takeda Pharmaceutical's Third-Quarter Net Profit Dropped on Lower Margins

31. jaan 2024, 23:58 UTC

Suurimad hinnamuutused turgudel

Protagonist Therapeutics Shares Rise 5.6% on Licensing Deal With Takeda

Võrdlus sarnastega

Hinnamuutus

Takeda Pharmaceutical Co Ltd ADR Prognoos

Hinnasiht

By TipRanks

6.02% tõus

12 kuu keskmine prognoos

Keskmine 14.8 USD  6.02%

Kõrge 14.8 USD

Madal 14.8 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Takeda Pharmaceutical Co Ltd ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

1

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

13.86 / 14.15Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

167 / 390 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

$